Investigation of the reasons for delayed presentation in proliferative diabetic retinopathy patients
PLOS ONE · 29.02.2024 · 19 (2) · e0291280
DOI: 10.1371/journal.pone.0291280 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 29.02.2024. Verfasst von Meng Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Tongren Hospiospital, Dongcheng Distri…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
To investigate reasons for delayed presentation in patients with proliferative diabetic retinopathy (PDR).
Methods
A questionnaire was designed to investigate consecutive PDR patients with delayed presentation who visited our center between January 2021 and December 2021. The questionnaire was divided into four sections: knowledge regarding diabetic retinopathy (DR), attitude toward DR treatment, difficulties adhering to follow-up plans, and medical care. The systemic disease status and severity of DR were recorded. Logistic analysis was undertaken to investigate DR treatment refusal and delay factors.
Results
A total of 157 patients were included in this study, with an average age of 50.0 ± 11.6 years. The median glycated hemoglobin level (HbA1c) was 7.8% (IQR 2.5%). Among the 157 eyes, most required vitrectomy intervention (144, 91.7%); 17 developed neovascular glaucoma (NVG), while only 13 required additional photocoagulation. Among the 36 patients with undiagnosed DM, the reason for delayed DR presentation was a lack of awareness of DM status among these patients (36 cases, 100.0%). Most of the patients with a known history of DM exhibited inadequate DR knowledge (29, 24.0%), believed their good visual acuity did not require DR screening (98, 81.0%), and had poorly controlled diabetes (113, 93.3%). Factors related to refusing DR treatment were patients with an inability to receive regular diabetes treatment in internal medicine clinics (OR 6.78, 95% CI 1.73–26.59, p = 0.006), patients who could not tolerate discomfort during ophthalmic examination and treatment (OR 15.15, 95% CI 2.70–83.33, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Tongren Hospiospital, Dongcheng District, Beijing, 100730, China.
- Mid & South Essex NHS Foundation Trust (Southend University Hospital) Prittlewell Chase Essex SS00RY, Southend-on-Sea, United Kingdom.
- Anglia Ruskin University, Cambridge, United Kingdom.
- Endocrinology, Beijing Tongren Hospital, Capital Medical University, Dongcheng District, Beijing, 100730, China.
Zitieren
APA
Zhao, M., Chandra, A., Liu, L., Zhang, L., Xu, J., & Li, J. (2024). Investigation of the reasons for delayed presentation in proliferative diabetic retinopathy patients. PLOS ONE, 19(2), e0291280. https://doi.org/10.1371/journal.pone.0291280
Vancouver
Zhao M, Chandra A, Liu L, Zhang L, Xu J, Li J. Investigation of the reasons for delayed presentation in proliferative diabetic retinopathy patients. PLOS ONE. 2024;19(2):e0291280. doi:10.1371/journal.pone.0291280
BibTeX
@article{Zhao2024,
author = {Zhao, Meng and Chandra, Aman and Liu, Lin and Zhang, Lin and Xu, Jun and Li, Jipeng},
title = {Investigation of the reasons for delayed presentation in proliferative diabetic retinopathy patients},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {2},
pages = {e0291280},
doi = {10.1371/journal.pone.0291280}
}
EUVIMED